BackASLAN Pharmaceuticals Overview

ASLAN Pharmaceuticals Intangible Assets

Latest intangible assets for ASLN: $0.

Get informed when a big investor buys or sells

+ Follow
Intangible Assets
$0.00

Peer trimmed avg / median

Loading

ASLAN Pharmaceuticals Intangible Assets History

Loading

ASLAN Pharmaceuticals vs. peers: Intangible Assets Comparison

Loading

ASLAN Pharmaceuticals Intangible Assets Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

ASLAN Pharmaceuticals (ASLN) FAQ

ASLAN Pharmaceuticals (ASLN) currently reports a intangible assets of $0 as of March 2024. In the prior-year period, the figure was $0. Use the charts on this page to explore ASLAN Pharmaceuticals's intangible assets history and peer comparisons.

ASLAN Pharmaceuticals's intangible assets changed from $0 to $0 (period ending March 2024). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

ASLAN Pharmaceuticals reported $0 in intangible assets as of March 2024. In the prior-year period, the figure was $0. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current intangible assets of $0, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for ASLAN Pharmaceuticals, and consider following ASLN for alerts when major investors trade the stock.

ASLAN Pharmaceuticals is classified in the Healthcare sector. On intangible assets, it currently shows $0. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing ASLN with unrelated industries.